This is a preview of subscription content, log in via an institution to check access.
Notes
2016 US dollars
Reference
Dahl NV, et al. Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA. ClinicoEconomics and Outcomes Research : 20 Sep 2017. Available from: URL: https://doi.org/10.2147/CEOR.S139950
Rights and permissions
About this article
Cite this article
Ferumoxytol cost effective for anaemia in patients with CKD. PharmacoEcon Outcomes News 788, 15 (2017). https://doi.org/10.1007/s40274-017-4383-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4383-z